↑ «Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives». Journal of Medicinal Chemistry, vol. 28, 9, 9-1985, pàg. 1252–1255. DOI: 10.1021/jm00147a022. PMID: 4032428.
↑ «Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD)». Journal of Medicinal Chemistry, vol. 45, 19, 9-2002, pàg. 4344–4349. DOI: 10.1021/jm020153s. PMID: 12213075.
↑ «Chemistry and Structure-Activity Relationships of Psychedelics». Current Topics in Behavioral Neurosciences, vol. 36, 2017, pàg. 1–43. DOI: 10.1007/7854_2017_475. PMID: 28401524.
↑ «Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)». Drug Testing and Analysis, vol. 8, 9, 9-2016, pàg. 891–902. DOI: 10.1002/dta.1884. PMC: 4829483. PMID: 26456305.
↑ «Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)». Drug Testing and Analysis, vol. 9, 1, 1-2017, pàg. 38–50. DOI: 10.1002/dta.1985. PMC: 5411264. PMID: 27265891.
↑ «Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD)». Drug Testing and Analysis, vol. 9, 10, 10-2017, pàg. 1641–1649. DOI: 10.1002/dta.2196. PMC: 6230477. PMID: 28342178.
↑ «Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)». Drug Testing and Analysis, vol. 10, 2, 2-2018, pàg. 310–322. DOI: 10.1002/dta.2222. PMC: 6230476. PMID: 28585392.
↑ «Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD)». Drug Testing and Analysis, vol. 11, 8, 8-2019, pàg. 1122–1133. DOI: 10.1002/dta.2613. PMC: 6899222. PMID: 31083768.
↑ «Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)». Psychopharmacology, vol. 236, 2, 2-2019, pàg. 799–808. DOI: 10.1007/s00213-018-5055-9. PMC: 6848745. PMID: 30298278.